digestive tract diseases(side effects and tolerance during esophageo-gastro-duodenoscopy)
Conditions
Interventions
electroacupuncture group:electroacupuncture + pharyngeal anesthesia with obucaine hydrochloride gel
sham electroacupuncture group:sham electroacupuncture + pharyngeal anesthesia with obucaine hydrochloride gel
pharyngeal anesthesia goup:pharyngeal anesthesia with obucaine hydrochloride gel
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75(included) years; 2. Patients with EDG indications; 3. ASA is rated as Grade I-III; 4. Patients who volunteered to participate in the study and provided informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with definite EDG contraindications; 2. Patients with neuropsychiatric disorders, severe anxiety and depression or no civil capacity; 3. Patients with serious or potential diseases, such as heart, brain, kidney, hematopoietic system and respiratory system diseases, may induce abnormal related indicators during EDG; 4. Patients who cannot accept acupuncture, electroacupuncture treatment or are allergic to acupuncture; 5. Patients known to be allergic to obucaine hydrochloride gel; 6. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the number and type of side effects during esophageo-gastro-duodenoscopy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tolerance and satisfaction with EDG;Postoperative discomfort;EDG smoothness; | — |
Countries
China
Contacts
Public ContactZhang Jie
The First Hospital of China Medical University
Outcome results
None listed